Stay updated on L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Sign up to get notified when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.

Latest updates to the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page
- Check5 days agoChange DetectedNew screenshot shows minor UI/layout refinements without altering core study details such as eligibility, interventions, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data and transaction delays due to funding lapses; previous v3.1.0 version tag removed.SummaryDifference7%

- Check41 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check55 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2; the 'Back to Top' item was removed.SummaryDifference0.4%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.4%

- Check69 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing various specific medical and pharmaceutical information related to hypertension and glaucoma.SummaryDifference4%

Stay in the know with updates to L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.